Grid AI expanded into hyperscaler AI datacenter market by integrating low-voltage grid technology.
Entero Therapeutics, Inc. (NASDAQ:ENTO), the parent company of Grid AI, announced the signing of a Letter of Intent to integrate the LV Grid engineering team and related intellectual property into Grid AI. The company views this addition as a critical step in Grid AI's strategy to capture a leading position in the rapidly expanding AI data-center energy-orchestration market. LV Grid's team, recognized for its deep experience in controls and energy optimization software, will join Grid AI to lead development of its AI Data Center Controls division. The integrated organization will deliver a digital-dispatch and campus-optimization engine, beginning with an AI data center energy park in Texas, positioned as a flagship Grid AI deployment designed to validate the economics of fully orchestrated behind-the-meter generation and storage for hyperscale operators.
Jason Sawyer, CEO of Entero, stated: "Grid AI is building the controls and optimization platform for one of the fastest-emerging asset classes in global energy. By integrating LV Grid's exceptional engineering talent and IP portfolio, we're accelerating time-to-market for a solution capable of monetizing AI-driven campus flexibility at scale. This combination strengthens our ability to capture recurring software revenues, high-margin optimization fees, and long-term enterprise relationships across the rapidly expanding hyperscaler ecosystem." Václav Moulis, CEO of LV Grid and incoming Chief Technology Officer of Grid AI, added: "Our team has spent years refining real-time energy-control architectures that blend physical generation, storage, and AI-workload dynamics. Joining Grid AI under Entero's platform gives us the capital support and commercial reach to deploy these systems globally, creating the technology and economic foundation for the next generation of intelligent power infrastructure."
According to Goldman Sachs estimates, more than 50 GW of incremental hyperscale datacenter power capacity will be required by 2028-2030, with power-delivery build-out costs averaging $6-12 billion per GW. This implies $300-600 billion in new capital formation, of which $10-20 billion is addressable by next-generation energy-optimization and digital-dispatch platforms. The transaction positions Grid AI at the center of this transformation, uniting control-system innovation with AI-driven orchestration software.
Entero Therapeutics is a publicly listed company whose programs have addressed significant unmet needs in gastrointestinal health through development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. Following the acquisition of Grid AI, the Company is repositioning into the infrastructure, AI and data-center orchestration space while operating Grid AI as a wholly-owned subsidiary. Grid AI is an AI-driven, grid-edge software and device orchestration platform enabling business, utility, and hyperscaler customers to forecast, optimize, and dispatch flexible demand, distributed energy resources and compute assets, with support for major ML frameworks and designed to deliver SaaS-like recurring revenue.